ABB · 4 days ago
Vice President – Pharma & Life Sciences
Cary, NC
Full-time
Onsite
Director/Executive
$139K/yr - $231K/yr
15+ years expABB is a global market leader committed to helping industries progress towards cleaner and leaner operations. The Vice President of Pharma & Life Sciences will lead the growth and expansion of ABB's Process Automation in the U.S. market, setting the vision and strategy while managing a cross-functional team to achieve significant business targets.
AutomotiveEnergyEnergy ManagementIndustrial AutomationRobotics
Responsibilities
Serve as subject matter expert on Pharma/Life Sciences trends (advanced therapy medicinal products, continuous manufacturing, digital quality, sustainability, etc.), competitive landscape, and regulatory drivers; translate insights into ABB portfolio requirements and channel strategy
Establish brand presence thought leadership content, conference keynotes, industry consortia (ISPE, PDA), and standards bodies positioning ABB as a trusted partner for GxP critical operations
Lead the entire U.S. Life Sciences commercial, marketing, and operations agenda, “end-to-end” from sales through service, acting as defacto CEO and future P&L owner of the segment
Build and own the opportunity funnel: set volume/price/mix targets, rigorously manage pipeline, and coach Capture Teams on complex pursuits (EPCM, MAC/MEC, Digital Transformation)
Design the operating model (sales, solution consulting, project delivery, service) and create staffing plans; recruit, onboard, and lead a high performing cross-functional team
Embed cGMP, FDA 21 CFR Part 11, GAMP 5, Data Integrity, ISO 13485, and HSE requirements into all solutions and delivery processes
Qualification
Required
Bachelor's in Engineering (Chemical, Electrical, Mechanical, Biomedical), or Biomedical Science
15+ years in Pharma/Biotech automation, MES, or EPC project business with ≥ 5 years P&L or segment leadership
Strategic yet hands-on mindset, able to craft vision and dive deep into day to day operations; possesses process knowledge that goes beyond automation
Extensive automation/domain knowhow in long cycle, largescale life sciences projects (> USD 1 B total installed cost), with proven oversight of substantial execution backlogs and value creation track record
Proven success closing $30 M–$100 M+ multisite automation or EPC contracts
Robust network with Engineering Firms, CMOs/CDMOs, Big Pharma, and industry consortia
Preferred
MSc preferred
Benefits
Choice between two medical plan options: A PPO plan called the Copay Plan OR a High Deductible Health Plan (with a Health Savings Account) called the High Deductible Plan.
Choice between two dental plan options: Core and Core Plus
Vision benefit
Company paid life insurance (2X base pay)
Company paid AD&D (1X base pay)
Voluntary life and AD&D – 100% employee paid up to maximums
Short Term Disability – up to 26 weeks – Company paid
Long Term Disability – 60% of pay – Company paid. Ability to “buy-up” to 66 2/3% of pay.
Supplemental benefits – 100% employee paid (Accident insurance, hospital indemnity, critical illness, pet insurance
Parental Leave – up to 6 weeks
Employee Assistance Program
Health Advocate support resources for mental/behavioral health, general health navigation and virtual health, and infertility/adoption
Employee discount program
401k Savings Plan with Company Contributions
Employee Stock Acquisition Plan (ESAP)
11 paid holidays
Company
ABB
ABB provides electrification and automation solutions for various industries.
10001+ employees
H1B Sponsorship
ABB has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (70)
2024 (51)
2023 (58)
2022 (63)
2021 (52)
2020 (46)
Funding
Current Stage
Public CompanyTotal Funding
$548.55MKey Investors
European Investment Bank
2023-11-21Post Ipo Debt· $545.85M
2013-09-23Grant· $2.7M
2001-04-06IPO
Leadership Team
Morten Wierod
CEO
Håvard Devold
Vice President, Market Development, Country Technology manager
Recent News
2025-12-17
Company data provided by crunchbase